Roles of glutamic pyruvate transaminase 2 in reprogramming of airway epithelial lipidomic and metabolomic profiles after smoking
Clinical and Translational Medicine · 2024-05 · 14 (5)
DOI: 10.1002/ctm2.1679 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Translational Medicine, online erschienen am 05.05.2024. Verfasst von Furong Yan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Center for Tumor Diagnosis & Therapy, Jinshan Hospital, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Lipidomics. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The National Natural Science Foundation of China, Joint funds for the Innovation of Science and Technology, Fujian province.
Abstract (Originalsprache)
Metabolic abnormalities represent one of the pathological features of chronic obstructive pulmonary disease (COPD). Glutamic pyruvate transaminase 2 (GPT2) is involved in glutamate metabolism and lipid synthesis pathways, whilst the exact roles of GPT2 in the occurrence and development of COPD remains uncertain. This study aims at investigating how GPT2 and the associated genes modulate smoking‐induced airway epithelial metabolism and damage by reprogramming lipid synthesis. The circulating or human airway epithelial metabolomic and lipidomic profiles of COPD patients or cell‐lines explored with smoking were assessed to elucidate the pivotal roles of GPT2 in reprogramming processes. We found that GPT2 regulate the reprogramming of lipid metabolisms caused by smoking, especially phosphatidylcholine (PC) and triacylglycerol (TAG), along with changes in the expression of lipid metabolism‐associated genes. GPT2 modulated cell sensitivities and survival in response to smoking by enhancing mitochondrial functions and maintaining lipid and energy homeostasis. Our findings provide evidence for the involvement of GPT2 in the reprogramming of airway epithelial lipids following smoking, as well as the molecular mechanisms underlying GPT2‐mediated regulation, which may offer an alternative of therapeutic strategies for chronic lung diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Tumor Diagnosis & Therapy, Jinshan Hospital, Fudan University, Shanghai, China.
- Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
- Center of Molecular Diagnosis and Therapy, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian, China.
- Department of Pediatric Surgery, Faculty of Pediatrics, the Seventh Medical Center of PLA General Hospital, Beijing, China.
- Department of Anesthesiology, Shanghai Geriatic Medical Center, Shanghai, China.
- Department of Anesthesiology, Zhongshan Hospital, Fudan University, Shanghai, China.
ORCID-Profile: Furong Yan, Liyang Li, Xuanqi Liu, Tiankui Qiao, Yiming Zeng, Duojiao Wu, Xiangdong Wang
Förderung
- The National Natural Science Foundation of China
- Joint funds for the Innovation of Science and Technology, Fujian province
Zitieren
APA
Yan, F., Zhang, L., Duan, L., Li, L., Liu, X., Liu, Y., Qiao, T., Zeng, Y., Fang, H., Wu, D., & Wang, X. (2024). Roles of glutamic pyruvate transaminase 2 in reprogramming of airway epithelial lipidomic and metabolomic profiles after smoking. Clinical and Translational Medicine, 14(5). https://doi.org/10.1002/ctm2.1679
Vancouver
Yan F, Zhang L, Duan L, Li L, Liu X, Liu Y, et al. Roles of glutamic pyruvate transaminase 2 in reprogramming of airway epithelial lipidomic and metabolomic profiles after smoking. Clinical and Translational Medicine. 2024;14(5). doi:10.1002/ctm2.1679
BibTeX
@article{Yan2024,
author = {Yan, Furong and Zhang, Linlin and Duan, Lian and Li, Liyang and Liu, Xuanqi and Liu, Yifei and Qiao, Tiankui and Zeng, Yiming and Fang, Hao and Wu, Duojiao and Wang, Xiangdong},
title = {Roles of glutamic pyruvate transaminase 2 in reprogramming of airway epithelial lipidomic and metabolomic profiles after smoking},
journal = {Clinical and Translational Medicine},
year = {2024},
volume = {14},
number = {5},
doi = {10.1002/ctm2.1679}
}
EUVIMED